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BACKGROUND
This protocol describes a study that will explore the lessons of
UNLOCK (Uncovering and Noting Long-term COPD and asthma to
enhance Knowledge) over the past 5 years of sharing real-life
primary care data from different countries to answer research
questions on the diagnosis and management of chronic
respiratory diseases.
UNLOCK is an international collaboration between primary care
researchers and practitioners to coordinate and share data sets of
relevant diagnostic and follow-up variables for chronic obstructive
pulmonary disease (COPD) and asthma management in primary
care. It was set up by members of the International Primary Care
Respiratory Group (IPCRG) in response to the identiﬁed research
need for research in primary care, which recruits patients
representative of primary care populations, evaluates interven-
tions realistically delivered within primary care and draws
conclusions that will be meaningful to professionals working
within primary care.1,2
The UNLOCK protocol summary was published in the Primary
Care Respiratory Journal in 2010.3 The primary purpose of
UNLOCK is to enable the validation of policy and treatment
decisions by using data from unselected primary care populations
from diverse contexts in very different countries to evaluate the
burden of disease (symptoms, limitations and exacerbations),
the natural history of disease, treatment and follow-up and
co-morbidities. The unique value of UNLOCK is that data are
drawn from primary care databases so there is the potential for
longitudinal and cross-sectional studies.
It has been 5 years since the UNLOCK collaboration began. In
that time its membership has expanded to include 15 countries:
Sweden, Spain, Ukraine, Canada, Greece, UK, Netherlands, Norway,
Australia, Portugal, Belgium, India, Germany, Uganda and Chile.
UNLOCK Group members now offer access to a range of data sets
including big data, such as routine healthcare data covering
millions of patients, and smaller data sets collected for speciﬁc
research purposes.
Individual members of the UNLOCK Group continue to show
they value the collaboration through their active participation in
twice-yearly meetings, collaboration on studies and the develop-
ment of new data sets. However, a range of practical issues have
hampered the UNLOCK Group’s ability to translate research ideas
into studies published in peer-reviewed publications. These
include structural challenges in working on a single study with
several researchers from different countries, such as cultural
differences; different language competencies and comfort in
discussing in English; variations in how COPD and asthma
diagnosis and management is reimbursed and incentivised in
primary care; the difﬁculties of participants combining a busy
demand-led primary care job with research, which is often unpaid
and unsupervised; and differences in primary care research
infrastructure and the value/credibility accorded to primary care
research.
Constraints in working with data sets from different countries
and collected for different purposes have also emerged. These
include the following:
● Different ethical and data protection requirements across
different countries.
● The highly variable size of data sets: 100 to 41,000,000
subjects.
● Differences in data variables and their deﬁnitions collected by
different countries.
● Differences in coding systems and practices.
● The absence of key variables in some data sets.
This study will analyse and share learning from the ﬁrst 5 years
of the UNLOCK collaboration.
AIMS
The objectives of this study are as follows:
1. To describe and classify the successes and motivation of
members of the UNLOCK Group in seeking to share real-life
data across regional and country borders to answer research
questions and how these have been captured/built upon;
2. To describe and classify the constraints experienced by
members of the UNLOCK Group in seeking to share real-life
data across regional and country borders to answer research
questions and how these have been overcome;
3. To identify methods to improve the effectiveness of future
studies involving data sharing across countries to inform future
research collaborations;
4. To describe other impacts of UNLOCK, including the develop-
ment of electronic recording systems, data validation and data
extraction.
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The study will answer the following research questions:
● What are the incentives, motivations and enablers for sharing
real-life data across regional and country borders?
● What are the challenges and constraints for sharing real-life
data across borders to answer research questions in the
experience of the UNLOCK Group?
● What strategies have been developed to overcome these and
how effective have they been?
● What lessons can be drawn about how to improve the
effectiveness of future studies involving data sharing across
borders?
● Are there any speciﬁc challenges to fostering the exchange of
primary care data in comparison with other data sets such as
public health, prescribing or hospital data?
● What are the core respiratory data variables that should be
collected nationally to enable chronic respiratory disease
research to better answer primary care research questions?
METHODS
Design
The study will use the following methodology:
● A document review of material related to the UNLOCK Group
using content analysis and thematic analysis to explore the
background, expectations, participation of members, develop-
ment of study ideas, planning of studies and progress reporting
at meetings compared with completion of studies. Documents
to be reviewed include the following: the UNLOCK protocol;
minutes of UNLOCK Group meetings; minutes of UNLOCK
Steering Committee meetings; study protocols; draft and
published UNLOCK studies; feedback from peer reviewers.
● A structured online questionnaire for UNLOCK Group members
to explore their perceptions of the strengths of the UNLOCK
Group, the barriers to participating in UNLOCK studies, how
these can be overcome and the learning to date.
● Structured interviews with UNLOCK Group members who have
acted as lead authors for UNLOCK studies to explore the barriers
to undertaking and completing UNLOCK studies, how these can
be overcome and the learning to date.
● A review of the data sets held by current UNLOCK members,
how these have changed over time and how many of these
data sets have been used for UNLOCK studies.
Analysis
Results from the literature review and the review of UNLOCK
documents will be coded thematically. The results of the online
questionnaire will be analysed by scoring participants’ prioritisa-
tion of key themes. The results of the structured interviews will be
analysed by scoring participants’ prioritisation of issues suggested
during questions. Responses to a smaller number of open
questions will be coded and thematically analysed.
Reporting
Reporting of ﬁndings will use Consolidated criteria for reporting
qualitative studies (COREQ).4 These standards ﬁt within the suite
of EQUATOR reporting guidelines.
DISCUSSION
This study will explore the UNLOCK Group’s experience of sharing
data from routine sources and research data sets. This is
particularly timely, as there is growing awareness among
healthcare planners, providers and researchers of the potential
to make better use of routinely collected health data to develop
population medicine approaches including disease prevention, as
well as targeted interventions such as risk stratiﬁcation and
personalised prescribing to improve outcomes. Research funders
have recently prioritised the challenge of ﬁnding ways to break
down data silos and translate data into actionable information.5
At the same time, there is increased emphasis on the need for
research data to be shared. In particular, the sharing of data offers
beneﬁts including more efﬁcient and faster progress in improving
health, better value for money and higher-quality science.
However, challenges in building the culture and resources needed
to support data sharing are considerable and include concerns
that researchers in resource-poor settings will lose out to better-
resourced researchers, fears that increased data sharing will create
unacceptable risks for patients and the costs in terms of money
and time of data sharing.6
The study will focus on data generated by primary care
clinicians and researchers to answer research questions of
relevance to primary care. There is consensus in policy documents
and research agendas that primary care has a key role in the ﬁght
against NCDs.7–10 Consequently, research needs to reﬂect primary
care priorities, including the need to improve evidence to
underpin the primary care approach to diagnosis and assessment
and broad management strategies.2
Furthermore, there is growing consensus that additional
evidence is needed about the process of translating basic
scientiﬁc discoveries into clinical practice, known as the ‘bench
to bedside continuum’. The proposed study will contribute to this
evidence by identifying successes, enablers, constraints, chal-
lenges and mechanisms to overcome these challenges experi-
enced by the UNLOCK Group as researchers and primary care
practitioners collaborating to answer primary care research
questions. The study will systematically capture and analyse this
learning through an implementation science approach. Imple-
mentation science can be deﬁned as follows:
The scientiﬁc study of methods to promote the systematic uptake
of clinical research ﬁndings and other evidence-based practices
into routine practice, and hence to improve the quality and
effectiveness of healthcare. It includes the study of inﬂuences on
healthcare professional and organisational behaviour.11
The experience the UNLOCK Group has developed in
exploring and seeking to overcome constraints and structural
challenges offers valuable learning for other researchers seeking
to share and to analyse data sets from different countries
to answer questions about the needs of primary care popula-
tions. The study is expected to identify recommendations on
study design and implementation, including ensuring
optimum data variables, primary care coding options, use of
data from multiple countries, use of data sets collected for
different purposes and ways to support primary care clinicians to
participate in research. Findings are also likely to be applicable
to other disciplines.
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